News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

|Videos|March 11, 2021

Virtual Exam Findings in an Infant Affected by Spinal Muscular Atrophy

Author(s)Diana Castro, MD, Garey H. Noritz, MD

Garey H. Noritz, MD, walks us through a virtual pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA).

Episodes in this series

EP. 1 Pediatric Neurological Exam to Identify SMA

EP. 1 Pediatric Neurological Exam to Identify SMA

EP. 2 Virtual Exam Findings in an Infant Affected by Spinal Muscular Atrophy

EP. 2 Virtual Exam Findings in an Infant Affected by Spinal Muscular Atrophy

EP. 3 Referral of SMA to a Neurologist

EP. 3 Referral of SMA to a Neurologist

EP. 4 Newborn Screening for SMA

EP. 4 Newborn Screening for SMA

EP. 5 Signs and Symptoms of SMA

EP. 5 Signs and Symptoms of SMA

EP. 6 Evaluation of Suspected SMA via In-Person and Remote Exam

EP. 6 Evaluation of Suspected SMA via In-Person and Remote Exam

EP. 7 Discussing the Diagnosis of SMA With the Family

EP. 7 Discussing the Diagnosis of SMA With the Family

EP. 8 SMA Resources for Physicians and Families

EP. 8 SMA Resources for Physicians and Families

EP. 9 Telehealth During COVID-19

EP. 9 Telehealth During COVID-19

EP. 10 Importance of Follow-Up Visits for SMA Amid COVID-19

EP. 10 Importance of Follow-Up Visits for SMA Amid COVID-19

EP. 11 Advice to Community Neurologists Treating SMA

EP. 11 Advice to Community Neurologists Treating SMA

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Content

Balu Krishnan, MD

Exploring the Integration of AI into the field of Epilepsy: Balu Krishnan, MD

ByLouie Pasculli

December 16th 2025

Andy Berkowski, MD, PhD

A Clinical Review of the 2025 Restless Leg Syndrome Guidelines

ByLouie Pasculli,Andy Berkowski, MD, PhD

December 16th 2025

Walter Kernan, MD (Credit: Yale University)

2024 Primary Stroke Prevention Guidelines: Key Takeaways and Clinical Implications

ByWalter Kernan, MD,Isabella Ciccone, MPH

December 16th 2025

Clinical Insights on the Long-Term Efficacy, Safety Profile of Bexicaserin in Developmental Epileptic Encephalopathies: Johannes Streffer, MD

ByJohannes Streffer, MD

December 16th 2025

Understanding the Therapeutic Potential and Promising Early-Stage Data on Azetukalner for Focal Onset Seizures

December 16th 2025

Latest CME

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Tolebrutinib Falls Short in Phase 3 PERSEUS Study, Forcing Decision to Redact Regulatory Submission

Understanding the Therapeutic Potential and Promising Early-Stage Data on Azetukalner for Focal Onset Seizures

A Clinical Review of the 2025 Restless Leg Syndrome Guidelines

Early Data of Neflamapimod Showing Potential Benefit in Dementia With Lewy Bodies: John-Paul Taylor, MBBS, PhD, MRCPsych

Clinical Insights on the Long-Term Efficacy, Safety Profile of Bexicaserin in Developmental Epileptic Encephalopathies: Johannes Streffer, MD

© 2025 MJH Life Sciences^®

All rights reserved.